Pancreatic Cancer Research

ResearcherAzienda Ospedaliero-Universitaria CareggiActive in the last 2 years

Daniele Lavacchi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5069705709. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 20… Co-author DOI 10.1186/s13045-026-01834-2↗
  2. Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration. Co-author DOI 10.3389/fonc.2025.1613773↗
  3. KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients. Co-author DOI 10.3389/fonc.2023.1295936↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Galli · 3 shared papers, 2023–2026 · strength 0.72
  2. Lorenzo Antonuzzo · 3 shared papers, 2023–2026 · strength 0.72
  3. Serena Pillozzi · 3 shared papers, 2023–2026 · strength 0.72
  4. Simone Polvani · 2 shared papers, 2023–2025 · strength 0.40
  5. Elisa Giommoni · 1 shared paper, 2026 · strength 0.32
  6. Giuseppe Defazio · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.